Oxford Immunotec (OXFD) Misses Q1 EPS by 1c

Oxford Immunotec (NASDAQ: OXFD) reported Q1 EPS of ($0.36), $0.01 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $21.5 million versus the consensus estimate of $21.2 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c